Xiaopeng Zhao1,2, Binbin Ma3, Shaokang Mo1, Lu Ma2, Fei Chang1, Liyuan Zhang1, Fang Xu4, Ling Wang5. 1. Reproductive Medical Center, General Hospital of Lanzhou Military Region, Lanzhou, China. 2. Key Laboratory of Reproduction and Genetics, Ningxia Medical University, Yinchuan, China. 3. School of Life Sciences of Biotechnology, Shanghai Jiao Tong University, Shanghai, China. 4. Key Laboratory of Reproduction and Genetics, Ningxia Medical University, Yinchuan, China. xufang@nxmu.edu.cn. 5. Reproductive Medical Center, General Hospital of Lanzhou Military Region, Lanzhou, China. szzxwangling@163.com.
Abstract
PURPOSE: The purpose of this study is to investigate the application value of the extended embryo culture for 7-8 h in day 3 morning during IVF-ET process. METHODS: Embryos were retrospectively assessed during 08:00-09:00 on the morning of day 3 in the control group, and were assessed once again at 16:00 in the afternoon in the extended culture (EC) group. The embryos with good developmental potential were preferentially selected to transfer. The cumulative pregnancy outcomes were analyzed in one oocyte retrieval cycle. RESULTS: Similar proportions were found in the rates of cumulative clinical pregnancy, cumulative live birth, and the perinatal/neonatal outcomes per oocyte retrieval cycle (P > 0.05). But higher total clinical pregnancy rate, higher total implantation rate, and lower total abortion rate were obtained in the EC group (P < 0.05). After EC, 53.58% of the embryos were able to continue to develop. The transferred embryos were mainly composed of ≥ 8-cell embryos (75.90%) in the EC group and ≤ 8-cell embryos (82.92%) in the control group. Interestingly, the implantation rates were increasingly improved with the increasing blastomere number up to 56.31% at the morula stage in the EC group, while they were limited to 32.33% at 8-cell stage in the control group. CONCLUSIONS: The extended culture of day 3 embryos for 7-8 h not only reduced the risk of IVF-ET treatment compared to blastocyst culture through another 2-3 days, but also improved the clinical outcomes and the efficiency of every transferred cycle and every transferred embryo.
PURPOSE: The purpose of this study is to investigate the application value of the extended embryo culture for 7-8 h in day 3 morning during IVF-ET process. METHODS: Embryos were retrospectively assessed during 08:00-09:00 on the morning of day 3 in the control group, and were assessed once again at 16:00 in the afternoon in the extended culture (EC) group. The embryos with good developmental potential were preferentially selected to transfer. The cumulative pregnancy outcomes were analyzed in one oocyte retrieval cycle. RESULTS: Similar proportions were found in the rates of cumulative clinical pregnancy, cumulative live birth, and the perinatal/neonatal outcomes per oocyte retrieval cycle (P > 0.05). But higher total clinical pregnancy rate, higher total implantation rate, and lower total abortion rate were obtained in the EC group (P < 0.05). After EC, 53.58% of the embryos were able to continue to develop. The transferred embryos were mainly composed of ≥ 8-cell embryos (75.90%) in the EC group and ≤ 8-cell embryos (82.92%) in the control group. Interestingly, the implantation rates were increasingly improved with the increasing blastomere number up to 56.31% at the morula stage in the EC group, while they were limited to 32.33% at 8-cell stage in the control group. CONCLUSIONS: The extended culture of day 3 embryos for 7-8 h not only reduced the risk of IVF-ET treatment compared to blastocyst culture through another 2-3 days, but also improved the clinical outcomes and the efficiency of every transferred cycle and every transferred embryo.
Authors: W P Martins; C O Nastri; L Rienzi; S Z van der Poel; C Gracia; C Racowsky Journal: Ultrasound Obstet Gynecol Date: 2017-04-10 Impact factor: 7.299
Authors: Evangelos G Papanikolaou; Efstratios M Kolibianakis; Herman Tournaye; Christos A Venetis; Human Fatemi; Basil Tarlatzis; Paul Devroey Journal: Hum Reprod Date: 2007-10-26 Impact factor: 6.918
Authors: Goedele Paternot; Alex M Wetzels; Fabienne Thonon; Anne Vansteenbrugge; Dorien Willemen; Johanna Devroe; Sophie Debrock; Thomas M D'Hooghe; Carl Spiessens Journal: Reprod Biol Endocrinol Date: 2011-09-15 Impact factor: 5.211
Authors: Manuel Belli; Paolo Rinaudo; Maria Grazia Palmerini; Elena Ruggeri; Sevastiani Antonouli; Stefania Annarita Nottola; Guido Macchiarelli Journal: Int J Environ Res Public Health Date: 2020-05-13 Impact factor: 3.390